Financial Contrast: Fresenius SE & Co. (FSNUY) and Its Peers

Fresenius SE & Co. (OTCMKTS:FSNUY) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Fresenius SE & Co. to similar companies based on the strength of its institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Fresenius SE & Co. and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius SE & Co.	0	0	3	0	3.00
Fresenius SE & Co. Competitors	4288	10570	18345	830	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 21.17%. Given Fresenius SE & Co.’s peers higher possible upside, analysts clearly believe Fresenius SE & Co. has less favorable growth aspects than its peers.

Profitability

This table compares Fresenius SE & Co. and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Fresenius SE & Co.	6.58%	10.24%	4.94%
Fresenius SE & Co. Competitors	-304.10%	-178.81%	-22.11%

Dividends

Fresenius SE & Co. pays an annual dividend of $0.20 per share and has a dividend yield of 1.3%. Fresenius SE & Co. pays out 25.0% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 40.4% of their earnings in the form of a dividend.

Earnings and Valuation

This table compares Fresenius SE & Co. and its peers gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Fresenius SE & Co.	$25.87 billion	$1.43 billion	18.74
Fresenius SE & Co. Competitors	$1.89 billion	$136.85 million	12.52

Fresenius SE & Co. has higher revenue and earnings than its peers. Fresenius SE & Co. is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

Fresenius SE & Co. has a beta of 0.63, suggesting that its stock price is 37% less volatile than the S&P 500. Comparatively, Fresenius SE & Co.’s peers have a beta of 2.57, suggesting that their average stock price is 157% more volatile than the S&P 500.

Institutional and Insider Ownership

40.6% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 15.0% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Fresenius SE & Co. beats its peers on 9 of the 15 factors compared.

About Fresenius SE & Co.

Fresenius SE & Co. KGaA is a German healthcare group headquartered in Bad Homburg. Its businesses include Fresenius Kabi, which supplies medicines, clinical nutrition, infusion therapies and medical technologies, and Fresenius Helios, which operates hospitals in Germany and Spain. Fresenius Kabi serves healthcare providers around the world, while Helios focuses on hospital and healthcare services in Europe. The group traces its origins to a pharmacy in Frankfurt acquired by pharmacist Eduard Fresenius in 1912.